School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

UNITED THERAPEUTICS Corp UTHR

Healthcare · Drug Manufacturers - Specialty & Generic

$549.16last close 2026-10-09 · market cap $23.55B · delayed data

Trailing returns

1M+8.35%
3M-0.60%
6M-4.46%
1Y+23.30%
5Y+181.07%

Basis: Adjusted daily closes.

What it does

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Open UTHR in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies